ISBT 128International Society of Blood Transfusion — Standard 128

ISBT 128 is the global standard for the terminology, identification, coding, and labelling of Medical Products of Human Origin (MPHO). It is administered by ICCBBA, a non-profit standards body. The current version is ST-001 — the ISBT 128 Standard Technical Specification — supplemented by dozens of implementation guides covering blood, cellular therapy, tissue, ocular, breast milk, and human reproductive tissue.

It is NOT a barcode symbology — it lives on top of Code 128 (linear) and Data Matrix (2D). It is NOT a regulation, though FDA recognises it as a means of meeting 21 CFR 606.121 container labelling requirements (and equivalents in EU, UK, Canada, Australia, Japan). It is the agreed grammar — vocabulary, data structures, encoding rules — that lets a unit labelled in Seoul be read and understood in Sydney.

The DIN is the anchor. It is unique across all ISBT 128 facilities globally for at least 100 years and is assigned to a donation event — a single donor at a single visit producing one or more components. Every component derived from that donation carries the same DIN plus its own product code (e.g. E0001V00 = Red Blood Cells, leukocytes reduced, AS-1, plastic, refrigerated).

An ISBT 128 blood-component container label is divided into four quadrants. The top-left quadrant carries the DIN as a Code 128 barcode and eye-readable. The top-right quadrant carries the ABO/Rh group as a Code 128 barcode and large eye-readable text. The bottom-left carries the product code as a barcode plus eye-readable product description. The bottom-right carries the expiration date and time as a barcode and eye-readable. Special testing results sit between the quadrants when required.

The label must also carry the facility identification number (FIN, assigned by ICCBBA), the proper name of the product, statements required by national regulation (in the US, the cautionary statements required by 21 CFR 606.122), the volume or weight, anticoagulant, and storage conditions. The Circular of Information accompanying the shipment carries the rest.

ISBT 128 has been extended beyond blood. The tissue product-code table covers musculoskeletal, skin, cardiovascular, dental, ocular, and birth-tissue products. The cellular-therapy table covers hematopoietic progenitor cells (HPC) from marrow, peripheral blood, and cord blood, plus T-cell, MSC, and other advanced therapy products. The reproductive table covers semen, oocyte, and embryo products.

AATB requires ISBT 128 for accredited tissue banks (since 2014 for new accreditations). NetCord-FACT and FACT-JACIE require it for cord blood banks and cellular therapy facilities. EU member states have adopted it for the Single European Code for tissues and cells under Directive 2015/565.

1. Obtain a Facility Identification Number (FIN) from ICCBBA. This is what tags every DIN with its origin facility.
2. Acquire the relevant technical specification and current product-code databases. ICCBBA publishes free reference databases that update monthly.
3. Validate the labelling system — label printer, software, barcode verifier — against ISBT 128 print quality requirements (currently ISO/IEC 15416 grade C or better for linear and ISO/IEC 15415 grade C for Data Matrix).
4. Validate the scanning workflow. Every handoff that changes status (collected, tested, released, shipped, received, transfused) should scan and write to the unit record.
5. Map national-regulator requirements (606.121 / 606.122 in the US, equivalent in EU / UK / etc.) to the ISBT 128 label layout and verify each label is satisfying both.